Rotavirus vaccine,live(pentavalent, Merck Sharp & Dohme)

轮状病毒疫苗（五价，默沙东）

Report date: 2026/05/08 20:02:52

Base Information

Drug NameRotavirus vaccine,live(pentavalent, Merck Sharp & Dohme)
Drug Alias Name五价重配轮状病毒减毒活疫苗（Vero细胞）RotaTeq乐儿德
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNorovirus InfectionsVomitingDiarrhea +[11] 
Global Approved IndicationsGastroenteritisRotavirus Infections
Approved Indications in ChinaRotavirus Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2006/02/03
Country/TerritoryBotswanaZambiaUnited States +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpMerck Sharp & Dohme Bv
Inactive CompaniesMerck & Co IncNational Institute Of Allergy And Infectious Diseases (Niaid)Merck Sharp & Dohme LLC +[4] 
Active IndicationsGastroenteritisRotavirus Infections
Inactive IndicationsNorovirus InfectionsVomitingDiarrhea +[9] 

Other Information

ATC CodeJ07BH02
Related LinksWikipedia